These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 38386317)

  • 1. Patient and Staff Perspectives on the Impacts and Challenges of Hospital-Based Harm Reduction.
    Fraimow-Wong L; Martín M; Thomas L; Giuliano R; Nguyen OK; Knight K; Suen LW
    JAMA Netw Open; 2024 Feb; 7(2):e240229. PubMed ID: 38386317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Harm Reduction and Treatment Among People at High Risk of Overdose.
    Bandara S; Byrne L; Berman V; Hurst A; King D; Gibbons JB; Sugarman OK; Livingston A; Kerins L; Hulsey EG; Alves A; Saloner B
    JAMA Netw Open; 2024 Aug; 7(8):e2427241. PubMed ID: 39133486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. People with lived and living experience of methamphetamine use and admission to hospital: what harm reduction do they suggest needs to be addressed?
    Forchuk C; Serrato J; Scott L
    Health Promot Chronic Dis Prev Can; 2023 Jun; 43(6):338-347. PubMed ID: 37466399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mobile addiction treatment and harm reduction services as tools to address health inequities: a community case study of the Brockton Neighborhood Health Center mobile unit.
    Pinkhover A; Celata K; Baker T; Chatterjee A; Lunze K
    Front Public Health; 2024; 12():1407522. PubMed ID: 38957203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meeting people where they are: implementing hospital-based substance use harm reduction.
    Perera R; Stephan L; Appa A; Giuliano R; Hoffman R; Lum P; Martin M
    Harm Reduct J; 2022 Feb; 19(1):14. PubMed ID: 35139877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrating Hospital-Based Harm Reduction Care-Harnessing the Nursing Model.
    Goff A; Lujan-Bear S; Titus H; Englander H
    Subst Use Addctn J; 2024 Apr; 45(2):307-313. PubMed ID: 38258867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recovery schools for improving behavioral and academic outcomes among students in recovery from substance use disorders: a systematic review.
    Hennessy EA; Tanner-Smith EE; Finch AJ; Sathe N; Kugley S
    Campbell Syst Rev; 2018; 14(1):1-86. PubMed ID: 37131375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A peer-delivered intervention to reduce harm and improve the well-being of homeless people with problem substance use: the SHARPS feasibility mixed-methods study.
    Parkes T; Matheson C; Carver H; Foster R; Budd J; Liddell D; Wallace J; Pauly B; Fotopoulou M; Burley A; Anderson I; MacLennan G
    Health Technol Assess; 2022 Feb; 26(14):1-128. PubMed ID: 35212621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient perspectives on a harm reduction-oriented addiction medicine consultation team implemented in a large acute care hospital.
    Hyshka E; Morris H; Anderson-Baron J; Nixon L; Dong K; Salvalaggio G
    Drug Alcohol Depend; 2019 Nov; 204():107523. PubMed ID: 31541875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integration of a community-based harm reduction program into a safety net hospital: a qualitative study.
    Khan GK; Harvey L; Johnson S; Long P; Kimmel S; Pierre C; Drainoni ML
    Harm Reduct J; 2022 Apr; 19(1):35. PubMed ID: 35414072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. People who use drugs engagement in substance use disorder services and harm reduction: evaluation, challenges and future direction of a community-based intervention.
    Gleason-Comstock J; Calhoun CB; Locke BJ; Boorle NVLD; Cobty K; McKenney T; Uddin KO; Bauer SJ; Xu J
    Subst Abuse Treat Prev Policy; 2024 Apr; 19(1):24. PubMed ID: 38689339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Collaborative approach to harm reduction by managed care pharmacy team for populations with substance use disorder.
    Osibanjo O; Reinhardt R; Clemans S; Andoniadis S; Carson P; Benkstein K
    J Am Pharm Assoc (2003); 2023; 63(1):396-402. PubMed ID: 36564331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substance use care innovations during COVID-19: barriers and facilitators to the provision of safer supply at a toronto COVID-19 isolation and recovery site.
    Kolla G; Tarannum CN; Fajber K; Worku F; Norris K; Long C; Fagundes R; Rucchetto A; Hannan E; Kikot R; Klaiman M; Firestone M; Bayoumi A; Laurence G; Hayman K
    Harm Reduct J; 2024 Jan; 21(1):17. PubMed ID: 38243267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multilevel Factors Impacting Substance Use Treatment Access, Engagement, and Racial Equity Among Opioid Overdose Survivors in Boston, MA.
    Paradise RK; Bazzi AR; Clarke J; Desmarais J; Hoyos-Cespedes A; Nurani A; O'Malley SE; Taylor S; Walley AY; Dooley D; Kimmel SD
    J Gen Intern Med; 2024 Oct; 39(13):2390-2399. PubMed ID: 38997532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "I wouldn't need Narcan for myself, but I can have it for somebody else:" perceptions of harm reduction among hospitalized patients with OUD.
    French R; Holliday Davis M; Aronowitz SV; Crowe M; Abrams M; Edwards G; Lowenstein M
    Addict Sci Clin Pract; 2023 Jun; 18(1):41. PubMed ID: 37355639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Harm reduction for the treatment of patients with severe injection-related infections: description of the Jackson SIRI Team.
    Serota DP; Tookes HE; Hervera B; Gayle BM; Roeck CR; Suarez E; Forrest DW; Kolber MA; Bartholomew TS; Rodriguez AE; Doblecki-Lewis S
    Ann Med; 2021 Dec; 53(1):1960-1968. PubMed ID: 34726095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Birth hospital and racial and ethnic differences in severe maternal morbidity in the state of California.
    Mujahid MS; Kan P; Leonard SA; Hailu EM; Wall-Wieler E; Abrams B; Main E; Profit J; Carmichael SL
    Am J Obstet Gynecol; 2021 Feb; 224(2):219.e1-219.e15. PubMed ID: 32798461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Barriers and Facilitators to Harm Reduction for Opioid Use Disorder: A Qualitative Study of People With Lived Experience.
    Westafer LM; Beck SA; Simon C; Potee B; Soares WE; Schoenfeld EM
    Ann Emerg Med; 2024 Apr; 83(4):340-350. PubMed ID: 38180403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Harm Reduction for Adolescents and Young Adults During the COVID-19 Pandemic: A Case Study of Community Care in Reach.
    Noyes E; Yeo E; Yerton M; Plakas I; Keyes S; Obando A; Gaeta JM; Taveras EM; Chatterjee A
    Public Health Rep; 2021 May; 136(3):301-308. PubMed ID: 33673755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug and alcohol treatment utilization and barriers among Black, American Indian/Alaskan Native, Latine, Asian/Pacific Islander/Native Hawaiian, and White adults: Findings from NESARC-III.
    Haeny AM; Oluwoye O; Cruz R; Iheanacho T; Jackson AB; Fisher S; Crouch M; O'Malley S
    J Subst Abuse Treat; 2021 Dec; 131():108569. PubMed ID: 34393011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.